Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pacific Biosciences of Ca...

    NASDAQ: PACB · Real-Time Price · USD
    1.13
    0.13 (13.00%)
    At close: Jun 06, 2025, 3:59 PM
    1.12
    -0.86%
    After-hours: Jun 06, 2025, 05:55 PM EDT

    Pacific Biosciences of California Statistics

    Share Statistics

    Pacific Biosciences of California has 300.08M shares outstanding. The number of shares has increased by 9.36% in one year.

    Shares Outstanding

    n/a
    		 300.08M

    Shares Change (YoY)

    n/a
    		 9.36%

    Shares Change (QoQ)

    n/a
    		 8.76%

    Owned by Institutions (%)

    n/a
    		 94.55%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 340,177

    FTD / Avg. Volume

    n/a
    		 3.91%

    Short Selling Information

    The latest short interest is 56.95M, so 18.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 56.95M

    Short % of Shares Out

    n/a
    		 18.98%

    Short % of Float

    n/a
    		 21.6%

    Short Ratio (days to cover)

    n/a
    		 7.18

    Valuation Ratios

    The PE ratio is -1.62 and the forward PE ratio is -1.9. Pacific Biosciences of California's PEG ratio is 0.25.

    PE Ratio

    n/a
    		 -1.62

    Forward PE

    n/a
    		 -1.9

    PS Ratio

    n/a
    		 3.26

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 0.99

    P/FCF Ratio

    n/a
    		 -2.37

    PEG Ratio

    n/a
    		 0.25
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pacific Biosciences of California.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.48, with a Debt / Equity ratio of 1.33.

    Current Ratio

    n/a
    		 7.48

    Quick Ratio

    n/a
    		 6.59

    Debt / Equity

    n/a
    		 1.33

    Debt / EBITDA

    n/a
    		 -2.77

    Debt / FCF

    n/a
    		 -3.17

    Interest Coverage

    n/a
    		 -26.57

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $267,850.43

    Profits Per Employee

    n/a
    		 $-538,871.3

    Employee Count

    n/a
    		 575

    Asset Turnover

    n/a
    		 0.12

    Inventory Turnover

    n/a
    		 1.99

    Taxes

    Income Tax

    n/a
    		 316K

    Effective Tax Rate

    n/a
    		 -0.1%

    Stock Price Statistics

    The stock price has increased by -51.22% in the last 52 weeks. The beta is 2.1, so Pacific Biosciences of California's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.1

    52-Week Price Change

    n/a
    		 -51.22%

    50-Day Moving Average

    n/a
    		 1.13

    200-Day Moving Average

    n/a
    		 1.59

    Relative Strength Index (RSI)

    n/a
    		 44.91

    Average Volume (20 Days)

    n/a
    		 8,691,600

    Income Statement

    In the last 12 months, Pacific Biosciences of California had revenue of 154.01M and earned -309.85M in profits. Earnings per share was -1.13.

    Revenue

    n/a
    		 154.01M

    Gross Profit

    n/a
    		 37.28M

    Operating Income

    n/a
    		 -356.38M

    Net Income

    n/a
    		 -309.85M

    EBITDA

    n/a
    		 -242.78M

    EBIT

    n/a
    		 -296.12M

    Earnings Per Share (EPS)

    n/a
    		 -1.13
    Full Income Statement

    Balance Sheet

    The company has 55.37M in cash and 672.43M in debt, giving a net cash position of -617.06M.

    Cash & Cash Equivalents

    n/a
    		 55.37M

    Total Debt

    n/a
    		 672.43M

    Net Cash

    n/a
    		 -617.06M

    Retained Earnings

    n/a
    		 -2.15B

    Total Assets

    n/a
    		 860.79M

    Working Capital

    n/a
    		 378.32M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -206.06M and capital expenditures -6.19M, giving a free cash flow of -212.25M.

    Operating Cash Flow

    n/a
    		 -206.06M

    Capital Expenditures

    n/a
    		 -6.19M

    Free Cash Flow

    n/a
    		 -212.25M

    FCF Per Share

    n/a
    		 -0.77
    Full Cash Flow Statement

    Margins

    Gross margin is 24.21%, with operating and profit margins of -231.4% and -201.18%.

    Gross Margin

    n/a
    		 24.21%

    Operating Margin

    n/a
    		 -231.4%

    Pretax Margin

    n/a
    		 -200.98%

    Profit Margin

    n/a
    		 -201.18%

    EBITDA Margin

    n/a
    		 -157.64%

    EBIT Margin

    n/a
    		 -231.4%

    FCF Margin

    n/a
    		 -137.81%

    Dividends & Yields

    PACB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PACB is $2, which is 100% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $2

    Price Target Difference

    n/a
    		 100%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.63

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist